MSN: The Inflation Reduction Act increases shingles vaccine use by 46% among Medicare Part D beneficiaries

TL/DR –

The Inflation Reduction Act has resulted in a 46% increase in shingles vaccine uptake for Medicare Part D recipients. This increase is significant, showing the effectiveness of the act in making the vaccine more accessible to those on Medicare. The data suggests that legislative measures can have a substantial positive impact on public health initiatives.

Inflation Reduction Act Increases Shingles Vaccine Uptake by 46% among Medicare Part D Recipients

Medicare Part D recipients have seen a significant 46% increase in shingles vaccine uptake, thanks to the Inflation Reduction Act. The Act, which aims to reduce the financial burden of essential services for seniors, has facilitated increased accessibility to vital vaccines.

Read More US Economic News